Page 30 - 82_01
P. 30

Coronary ischemia-reperfusion: role of nitric oxide and endothelin-1. A Review

subsequent studies have confirmed these observations, as       types of cells. Interactions between endothelial cells and
brief periods of ischemia, including partial ischemia,         cardiomyocytes could be of significance in regulating
impairs coronary vasodilator responses and enhances            cardiac function by modulating vascular tone and by
coronary vasoconstrictor responses, and that these             stimulating proliferation of neighboring cells. This aspect
alterations are accentuated after prolonged periods of         may be of relevance in situations such as ischemia and
ischemia accompanied by myocardial infarction, and they        reperfusion (149).
affect both epicardial and microvascular coronary
functional ability (135-140). The mediators of the                 There are studies showing that NO may be detrimental,
impairment in coronary vasomotor function after ischemia-      and also studies showing that NO may be critical to
reperfusion remain uncertain; it may be involved reactive      preserve cardiomyocytes function and viability after
oxygen species (138), plaque rupture with embolization of      ischemia-reperfusion. In a Review published by R. Bolli in
particulate debris and release of vasoconstrictors             2001 it is indicated that “Of the 92 studies that have
(serotonin, thromboxane (141, 142) ), and inflammatory         examined the role of NO in modulating the severity of
mediators, particularly TNFa (143, 144).                       ischemia-reperfusion injury in unstressed myocardium, the
                                                               vast majority (73%) have concluded that NO (either
    More recent studies support the idea that NO and ET-1      endogenous or exogenous) has a protective effect, and
play a relevant role at various subclinical and clinical       only 12% found a detrimental effect. The proportion of
stages of the coronary artery disease, and particularly after  studies supporting a citoprotective role of NO is similar for
myocardial ischemia-reperfusion. The NO/ET-1 axis could        in vivo and in vitro preparations” (150). The cardiac
play an important role in pathophysiology of myocardial        interstitial NO concentration may increase during early
ischemia-reperfusion and of reperfusion injury, and            ischemia and early reperfusion, and this increase may be in
beneficial effects of some therapeutical strategies for        part derived from activated NOS isoforms but also from
myocardial reperfusion injury are attributed to                NOS-independent pathways. The cardiac interstitial NO
modification of this axis. This particular issue, however,     concentration is within the nanomolar range during normal
remains to be resolved and the available results are           perfusion. And during ischemia, NOS3 activity is
contradictory. As NO and ET-1 may interact for regulating      increased within minutes, and subsequently the NO
the function of coronary vasculature and the myocardium,       concentration during early ischemia is increased (151).
the study of these two substances probably should be           However, with prolonged myocardial ischemia, NOS3
considered together. NO is produced by both coronary           protein expression decreases, and the tissue acidosis
endothelial cells and cardiomyocytes, and the principal        attenuates NOS3 activity (153). Within the early seconds
source of this NO is eNOS (NOS3); in cardiomyocites            of reperfusion, the NO concentration is increased (154),
NOS1 may be also involved, and expression of both NOS1         and if reperfusion is prolonged, NOS activity and thus NO
and NOS3 in these cells appears to be species-dependent        concentration decrease below baseline values (155).
(for this issue, see References 36, 145-148). On the other     Decreased NO production during reperfusion have been
hand, NO seems to play a relevant role in the functional       suggested by observations indicating loss of NO-
regulation of myocardium under normal conditions and           dependent vasodilation in response to Achor bradykinin, or
after ischemia-reperfusion (36, 147-149). Several studies      loss of vasoconstriction in response to NOS inhibition (for
demonstrate that biosynthesis of NO by constitutive NOS        details, see Reference 146). During myocardial ischemia-
(endogenous NO) plays a critical role in alleviating the       reperfusion, reduced production of endogenous NO could
severity of myocardial ischemia-reperfusion as well as         leave unopposed coronary vasoconstriction to the presence
reperfusion injury. NO has been known to play various          of vasoconstrictors such as ET-1. This disbalance between
functional and pathological roles as an intracellular or       NO and ET-1 in turn enhances vascular tone, decreases
intercellular messenger in the heart, and there are data       coronary blood flow and exacerbates reperfusion injury.
indicating that NO can both reduce and mediate
myocardial reperfusion injury. NO influences myocardial            From the results obtained in a study performed in rat
perfusion by regulating coronary vascular function,            hearts, it is suggested that during reperfusion, cardiac
causing a direct vasodilatory effect and modulating            function is depressed, despite increased rather than
vascular reactivity to other types of vasoactive stimuli (e.   decreased endogenous NO production, largely due to the
g. ET-1). NO can also influence indirectly myocardial          prevalence of the deleterious effects of ET-1. These
perfusion by regulating leukocyte–endothelial cell             adverse effects of ET-1 can be overcome by antagonism of
interaction, inhibiting platelet adhesion and aggregation,     ET-1 receptors or exogenous NO supplied by NO donors
attenuating smooth muscle cell proliferation, and possible     (156). In other study performed in anesthetized pigs (157),
modulation of cardiomyocytes function. NO released from        it was examined the interaction between the
the endothelium has also been shown to inhibit surface         cardioprotective effect of endothelin receptor blockade and
expression of many endothelial cell adhesion molecules         NO during ischemia-reperfusion injury. The authors of this
(ECAMs), including P-selectin, E-selectin, VCAM-1, and         study suggest that blockade of endothelin ETA receptors
ICAM-1 (for this issue, see Reference147). Also, as            produces cardioprotective effects, and that this
cardiomyocytes are surrounded by capillary endothelial         cardioprotection is mediated via a mechanism related to
cells it allows for cell-to-cell signaling between these two   NO (157).

@Real Academia Nacional de Farmacia. Spain                                      29
   25   26   27   28   29   30   31   32   33   34   35